Atlanto-occipital CSF catheter. A spinal Tuohy needle (18-gauge, 9 cm) from a freshly opened epidural kit (Mila International, Florence, KY) was inserted into the subarachnoid space (cisterna magna, site confirmed by needle "pop" and aspiration of CSF). The catheter (20-gauge, 9203 wire reinforced, closed end) was threaded 10 -15 cm into the space, the needle was withdrawn, and a sampling adaptor and cap were attached to the open end of the tube. The catheter was fixed in place with a butterfly tape and sutures near the skincatheter interface. The sampling tip was closed with an infusion cap, wrapped in sterile gauze soaked in chlorhexidine acetate 1% (Hibitane Veterinary Ointment; Wyeth Animal Health, Division of Wyeth Canada, Guelph, ON, Canada), and placed in a sterile plastic bag.
Jugular intravenous catheters. A sterile catheter was made using sterile vinyl tube (Dural Plastics and Engineering, Auburn, Australia) with an inner diameter of 1 mm and a length of 45 cm. The catheter was inserted through a needle into the jugular vein. The catheter was placed 25-30 cm into the vein (depending on the calf body weight) so that the tip lay in the anterior vena cava. The sampling end was tunneled subcutaneously (5-6 cm) to reduce the possibility of thrombophlebitis. Both jugular veins were catheterized; one catheter was used for infusion and the other for venous blood sampling. The entire neck was covered with sterile dressing to protect the three catheters. Pockets in the dressing allowed access to the catheters.
Ear arterial catheter. A freshly opened arterial catheter (22-gauge, 0.9 ϫ 25 mm, BD Insyte; Becton-Dickinson Infusion Systems, Sandy, UT) was placed in the ear artery on the dorsal surface of one of the ears for arterial sampling.
Postsurgical Care
The postsurgical rest period was a minimum of 4 days, during which the catheterized calves were treated with an antibiotic, enrofloxacin (5 mg/kg Baytril 100 injectable solution; Bayer HealthCare, Bayer, Animal Health Division, Toronto, ON, Canada) and an analgesic, ketoprofen (3 mg/kg Anafen 100; Merial Canada, Baie d'Urfe, QC, Canada) intramuscularly. Sixteen calves were surgically catheterized; eight remained healthy with functioning catheters and were used for infusions (Table 1) . Following completion of the experiment, two calves were euthanized and the locations of the catheters confirmed at necropsy. The placement of CSF catheters in surviving calves was confirmed by contrast radiology.
Experimental Design
The calves (n ϭ 8) with indwelling CSF, venous, and arterial blood catheters were experimentally infused for 6 h with solutions of DL-lactic acid (DL-LA), L-lactic acid (L-LA), hydrochloric acid (HCl), or physiological saline (NaCl) as a control. The order of treatments was randomly assigned. CSF fluid and venous and arterial blood were sampled over a 24-h period and concentrations for D-and L-lactic acid and blood gas values were determined. Neurological assessments of the calves were also carried out throughout the experimental period. The study received approval from the Animal Care Committee of the University of Saskatchewan and was carried out in accordance with the guidelines specified by the Canadian Council on Animal Care (8) .
Infusates and Infusion Protocol
DL-LA, L-LA (Sigma-Aldrich, St. Louis, MO), and HCl (BDH, Toronto, ON, Canada) were formulated as 300 mmol/l solutions while saline (NaCl; EMD Chemicals, Gibbstown, NJ) was 150 mmol/l; pH values (means Ϯ SE) for the four solutions were 2.5 Ϯ 0.1, 2.6 Ϯ 0.1, 1.2 Ϯ 0.2, and 5.6 Ϯ 0.1, respectively. By analysis, DL-LA contained 53% D-lactate and 47% L-lactate. All infusates were autoclaved prior to use. A separate experiment with three sets of solution documented a small loss in weight to 99.93 Ϯ 0.02% of the original weight and no loss of lactate or its isomers following autoclaving; for DL-lactate solutions, D-lactate concentrations were 141.5 Ϯ 1.4 and 144.7 Ϯ 1.1 mmol/l, L-lactate 146.5 Ϯ 2.0 and 150.6 Ϯ 1.4 mmol/l pre-and postautoclaving, respectively.
The eight calves randomly received intravenous infusions of DL-LA, L-LA, HCl, or saline (Table 1) at an infusion rate of 20 ml ⅐ kg body wt Ϫ1 ⅐ h Ϫ1 using an automated infusion pump (Imed 980 volumetric infusion pump; Imed, San Diego, CA) for 4 h. Infusion was continued for a further 2 h or until venous pH reached 7.05. If pH rose above 7.1 infusion was restarted. After 12 h from the beginning of the infusion, severely acidotic calves were treated with 155 mmol/l NaHCO 3 solution (Sigma-Aldrich, St. Louis, MO) to correct blood pH and alleviate neurological disturbances. There was a minimum period of 2 days between each infusion.
Sampling and Measurements
Samples of CSF fluid (ϳ0.7 ml) and venous (4 ml) and arterial (1 ml) blood were collected, and neurological assessment was performed at Ϫ1 (preinfusion), 0 (start of infusion), 1, 2, 3, 4, 5, 6 (completion of infusion), 7 (postinfusion), 8, 10 , and 24 h.
Neurological assessment was performed by a veterinarian who was blinded to the type of infusion being administered. Neurological function was scored on the basis of the strength of the suck, menace, palpebral, and tactile reflexes and ability to stand (34, 38, 41) . Each item was given a score of from 0 (normal) to 2 (severely abnormal) according to a previously published scale (34) . The values were summated to produce a total neurological score (TNS). Calves with normal CNS function had scores of 0, whereas severely obtunded calves could have a maximum score of 10.
Laboratory Analyses
Heparinized arterial and venous blood (1 ml each) and 0.3 ml of CSF fluid were placed on ice and analyzed within 40 min of collection for pH, bicarbonate (HCO 3 Ϫ ), base excess, partial pressure of carbon dioxide and oxygen (PCO2 and PO2) using a blood gas analyzer (ABL 5; Radiometer Medical, Copenhagen, Denmark) (55) . Hemoglobin and its oxygenation status were measured in a hemoximeter (OSM3; Radiometer Medical) (68) .
The remaining venous blood (3 ml) was allowed to coagulate for 20 min, and serum was separated in a refrigerated centrifuge (IEC Centra-7R Refrigerated Centrifuge; International Equipment, Needham Heights, MA) at 1,000 RCF for 30 min. The serum and remaining CSF fluid were stored at Ϫ20°C. D-LA and L-LA concentrations were measured using an HPLC system (Waters 600 HPLC pump, 486 UV detector, 786 Ultra WISP autoinjector, and Millenium v. 4 software; Waters, Mississauga, ON, Canada) as we previously described (46) . Infusate pH was measured using a pH meter (Beckman Ø 32 pH meter; Beckman Instruments, Fullerton, CA).
Statistical Analysis
Graphs and figures were created using a spreadsheet (Microsoft Excel; Microsoft, Redmond, WA). Descriptive statistics and Pearson correlation coefficients were calculated using a statistical analytical software package (SPSS statistical software v. 13, 2005 ; SPSS, Chicago, IL). Analysis of variance (ANOVA) with repeated measures was carried out using SAS statistical software (SAS/STAT statistical software package for Windows, v. 8.02; SAS Institute, Cary, NC). The significance of treatment effects on neurological scores, blood gas values, and serum and CSF lactates was determined by repeatedmeasures ANOVA using treatment (infusion) as the independent variable (59) . Mean values at individual time points were compared using the Student-Newman-Keuls (SNK) test. Treatment differences were also tested using orthogonal contrasts to compare DL-LA vs. HCl, L-LA, and saline. A P value of Յ0.05 was considered to be statistically significant. Values are reported as means Ϯ SE.
RESULTS
All infusions were continued for 6 h except for HCl, which was given intermittently between hours 4 and 6 to maintain venous pH above 7.0 and below 7.10.
Neurological Assessment
Saline had no effect on neurological score (Fig. 1 ). L-LA and HCl infusions produced mild impairments in neurological function and had no significant effect on the menace, tactile, and palpebral reflexes at any time period. DL-LA-infused calves had a significantly reduced menace reflex between 1 and 10 h; the menace response was completely absent at 6, 7, and 8 h of infusion. Ability to stand was significantly inhibited by DL-LA infusion between 2 and 10 h; weakness was detected at 2 h, developed into ataxia at 4 h, and progressed to involuntary recumbency at 8 h. During infusions other than DL-LA, involuntary recumbency was only seen on one occasion, in a calf receiving L-LA. In DL-LA-infused calves, significant reductions in the palpebral and tactile reflexes were first detected at 3 h, increased to maximum at 7 or 8 h, and slightly recovered by 10 h. The suck reflex was unusual in that HCl and DL-LA similarly depressed this reflex; L-LA had a smaller effect (Fig. 2) .
Acidosis
HCl infusion produced the most severe metabolic acidosis, which reached a nadir at 4 h of infusion; venous blood pH 6.9 Ϯ 0.1, bicarbonate 7.00 Ϯ 1.45 mmol/l, and base excess (BE) Ϫ23.3 Ϯ 1.7 mmol/l. DL-LA produced a significantly less severe acidemia than HCl; at 6 h, pH 7.13 Ϯ 0.06 and 7.00 Ϯ 0.04, bicarbonate 11 Ϯ 1 and 8 Ϯ 1 mmol/l and base excess Ϫ16 Ϯ 1 and Ϫ23 Ϯ 3 mmol/l for DL-LA and HCl, respectively, all P Ͻ 0.01. In contrast, L-LA infusion resulted in little change in acidemia with blood gas values similar to those during saline infusion ( Table 2) .
Both HCl and DL-LA infusions produced similar decreases in CSF pH (Fig. 3) , bicarbonate (Fig. 4) and PCO 2 ( Table 2) . Arterial blood bicarbonate (r ϭ 0.87), BE (r ϭ 0.84), and PCO 2 (r ϭ 0.78) were highly correlated (P Ͻ 0.01) with the corresponding CSF measurements. However, arterial and CSF pH were only moderately correlated (r ϭ 0.57). The correlations between CSF and venous blood gas measurements were not as strong; correlations for CSF and venous blood measurements of bicarbonate, PCO 2 and pH were 0.85, 0.56, and 0.46 respectively.
D-and L-Lactate Concentrations
Serum and CSF D-lactate were increased only by DL-LA infusion. Venous serum and CSF D-lactate concentrations were highly correlated (r ϭ 0.91, P Ͻ 0.01). However, changes in CSF D-lactate lagged behind those in serum (Fig. 5) .
Serum L-lactate concentrations were unaffected by HCl infusion, increased to a moderate extent during DL-LA infusion, and were highest during L-LA infusion. CSF L-lactates were also highest with L-LA infusion and moderately increased with DL-LA infusion (Table 2) . During L-LA infusion, peak CSF L-lactate concentrations were attained at 6 h (11 Ϯ 1 mmol/l) and were slightly higher than peak serum L-lA concentration (10 Ϯ 1 mmol/l). During DL-LA infusion, CSF L-LA concentration (8 Ϯ 1 mmol/l) peaked at 6 h and was 60% higher than serum concentration (5 Ϯ 2 mmol/l). During DL-LA infusion, peak serum and CSF L-LA concentrations were considerably lower than those of peak D-lactate concentrations ( Table 2) .
Clearance of D-lactate
Following cessation of infusion, serum D-lactate concentrations declined in an exponential fashion with time (r ϭ 0.98, P Ͻ 0.01). Clearance of D-lactate from CSF was slower and more gradual than from serum (Fig. 5) . CSF clearance was constant over the 12-h postinfusion period, whereas clearance from serum declined with time and correlated (r ϭ 0.73, P Ͻ 0.01) with serum D-lactate concentration.
Correlation of Neurological Disturbances with Changes in Blood and CSF Chemistry
CSF and serum D-lactate concentrations strongly correlated (P Ͻ 0.01) with all neurological scores except for the strength of the suck reflex ( Table 3 ). The suck reflex was affected similarly by both DL-LA and HCl infusions (Fig. 2) and was better correlated with CSF bicarbonate, BE, or pH than with CSF D-lactate concentration (Table 3) . Arterial or CSF pH or bicarbonate correlated weakly with other reflexes and with total neurological score ( Table 3) .
DISCUSSION
D-Lactic acidosis has been associated with neurological dysfunction in a variety of species, including humans, cattle, cats, and dogs (31, 48, 50, 64) . The reported signs in humans include slurred speech, loss of reflexes, abnormal gate, ataxia, paresis, and sometimes coma. In calves (37) and cats (48) , impairment of palpebral and menace reflexes have been reported in association with other neurological disturbances. Although clinical studies have consistently shown an association between D-lactate concentration and neurological disturbance, a causal link has not been established (28, 31, 48, 50, 64, 67) . In many of these studies, other parameters, such as acidemia, were also associated with CNS impairment. In our study, severe acidemia with only mild impairments of neurological function were induced by HCl infusion, whereas DL-LA infusion produced less acidemia but severe neurological derangements (Fig. 1) . The derangements observed with DL-LA are similar to those reported clinically for D-lactic acidosis and include decreased palpebral and menace reflexes, ataxia, involuntary recumbency, and a comatose appearance. This toxicity is independent of changes in blood or CSF pH, because HCl infusion produced a more severe metabolic acidosis and a similar CSF acidosis but only small changes in neurological function. Toxicity is also unrelated to the L-LA component of the DL-LA infusion as infusion of pure L-LA produced a more marked L-lactatemia but had only small effects on neurological function. Thus, D-lactate was the neurotoxic agent in our study. The majority of the infused D-lactic acid would dissociate into D-lactate and hydrogen ions in the blood stream. The conclusion that D-lactate is neurotoxic is supported by the high correlation between CSF D-lactate concentrations and neurological disturbances (Table 3) . A secondary role for L-LA cannot be completely excluded, as this was also infused. L-LA has been previously shown to affect D-lactic acid metabolism (11) . However, our inference that D-lactate is neurotoxic is consistent with earlier work in which signs of ataxia, somnolence, and impaired palpebral reflexes developed following hypertonic sodium D-lactate injection in calves (37) . Our experiment also indicates that D-lactate, not hypertonicity as some have proposed (57) , is the toxic agent. D-Lactate may be (39, 56) . Hence, either D-lactate or D-lactic acid may be the toxic agent intracellularly.
In previous experiments, oral administration of DL-LA did not significantly influence humans physiologically or pathologically (15) . This lack of effect can be explained by the much smaller amounts of DL-LA administered, a maximum of 12.8 mmol/kg 0.75 of racemic DL-LA per day. The total dosage administered in the present experiment was eight times higher. Consequently, plasma D-lactate did not exceed 1 mmol/l in the previous experiment, whereas we obtained peak serum concentrations of ϳ36 mmol/l. Clinical reports of neurological dysfunction suggest that D-lactate concentrations would have to be at least 3 mmol/l before clinical signs are seen (64) .
In the present study, the suck reflex (Fig. 2) was correlated more strongly with CSF bicarbonate, BE, and pH than with CSF D-lactate concentration (Table 3) . Similarly, clinical studies in calves have noted that ataxia and loss of the palpebral reflex are correlated with D-lactate concentrations whereas the strength of the suck reflex is correlated with acidemia (36) . Taken together, this work suggests that acidemia depresses the suck reflex but is not responsible for ataxia or changes in the palpebral reflex.
In the present study, neurological depression was first observed at 2 h of DL-LA infusion when mean serum D-lactate was 16 Ϯ 1 mmol/l, which is higher than the serum D-lactate concentrations of ϳ3 mmol/l reported in some clinical cases (64) . Our previous studies established that diarrheic calves with neurological depression have serum D-lactate concentrations as high as 26 mmol/l (17, 47) . The serum D-lactate concentrations in our current infusion study are well below the serum value (110 mmol/l) reported in a patient intoxicated after overingestion of propylene glycol (31) . Furthermore, our data show that it takes time for D-lactate to diffuse into the CSF. At 1 h of infusion, mean serum D-lactate was 11 Ϯ 1 mmol/l but CSF D-lactate was 2 Ϯ 1 mmol/l. It is possible that a more gradual infusion would result in greater equilibration between CSF and blood D-lactate concentrations with clinical signs at lower venous serum D-lactate concentrations.
In the brain, astrocytes are net producers of L-lactate, because their arms are too thin to accommodate mitochondria (26, 29) . The L-lactate is metabolized by neurons (2, 7, 29, 40, 54) . It has been estimated that 75% of neuronal oxygen consumption is accounted for by L-lactate metabolism and 25% by glucose metabolism (7) . Lactate utilization may be particularly important during acidemia, since low pH can inhibit phosphofructokinase activity, a key glycolytic regulatory enzyme (35) . In neurons, uptake of L-lactate is close to saturation at physiological L-lactate concentrations (25) . D-Lactate blocks the ability of isolated optic nerves to generate an action potential, probably by competitively blocking L-lactate entry into neurons and limiting neuronal metabolism (61, 62) . L-lactate can act as an energy source during ischemia-reperfusion injury and reduces cerebral injury (9, 52) . In contrast, D-lactate enhances neuronal injury in ischemia-reperfusion models (9) . Although, D-lactate dehydrogenase is found in mammalian mitochondria, particularly in liver and kidney, it is poorly expressed in human brain tissue (20) . It is therefore possible that the neurotoxic effects of D-lactic acid infusion observed in the present study are the result of reduced L-lactate availability within neurons and energy deficit. In support of this, the serum-CSF L-lactate difference was slightly greater during DL-LA infusion; this may reflect reduced neuronal removal of astrocyte produced L-lactate (Table 2) . Similarly, others have shown that blockade of neuronal monocarboxylate transporters responsible for L-lactate entry results in increased neuronal cell death in the developing brain (1) .
Rapid ethanol consumption is another situation wherein acute neurological disturbances are observed in humans (24) . We were impressed with the "drunken" appearance of our calves during DL-LA infusion. In acute ethanol consumption, neurological depression may be caused by low concentrations of circulating tryptophan (3) or interactions with the GABA A receptor complex and facilitation of GABA action (23, 58) . However, ethanol also has early effects on energy metabolism (1, 33, 65) , which may be similar to some of the actions of D-lactate.
In addition to lipid-mediated penetration (45), L-lactate may be transported across the blood-brain barrier by monocarboxylic acid transporters (22, 25, 54) , which are stereospecific (61, 62) . During DL-LA infusion, CSF L-lactate concentrations increased steadily and were higher than serum concentrations by a similar amount in all infusions (Table 2 ). L-Lactate was probably being formed within nervous tissue by metabolism of glucose, and this likely contributes to the higher concentrations in CSF (2, 22) . In our experiment, D-lactate rapidly crossed the blood-brain barrier, although CSF concentrations were about one-half those of serum (Table 2 ). This could be explained by serum L-lactate competing with serum D-lactate for uptake from blood by CSF tissue (61, 62) .
In the present study and in previous work (37) , serum D-lactate exhibited an exponential decay. However, CSF D-lactate clearance was constant over the period studied. Although D-lactate infusion was stopped at 6 h, serum D-lactate concentrations were still higher than those in CSF; this likely resulted in some transfer into the CSF confounding the calculations of clearance. At 10 h, CSF D-lactate concentrations were higher than in serum; the slow disappearance of CSF D-lactate would explain the prolonged neurological disturbance and encephalopathy observed in many clinical D-lactic acidosis cases even after treatment has been initiated (50, 51, 64) . Monocarboxylic transporters may remove D-lactate from CSF (61, 62) . D-Lactate in blood may be taken up by hepatic and extrahepatic tissue (13, 42) , although some is excreted in urine (11, 17, 18, 32, 44, 63) . Serum L-lactate clearance was not exponential. Previous studies show that serum L-lactate is cleared through two independent processes: hepatic removal follows second-order kinetics, whereas extrasplanchnic removal is linearly related to serum concentration (42) .
In conclusion, D-lactate is a potent neurotoxic agent. In acidemic calves, the majority of neurological disturbances (i.e., ataxia and depressed menace, palpebral, and tactile reflexes) are related to D-lactate accumulation in CSF rather than in blood or to acidosis in CSF. However, HCl infusion has mild depressive effects on neurological function, and the suck reflex was similarly depressed by both DL-LA and HCl infusions. D-Lactate accumulation may be responsible for the majority of clinical signs of depression and loss of function in a variety of diseases, including neonatal calf diarrhea and other animal and human syndromes characterized by D-lactic acidosis. Research needs to be undertaken to determine the precise mechanism of neurological depression caused by D-lactate.
